Drug
Trastuzumab Emtansine
Trastuzumab Emtansine: highest development phase Phase 3, developed by Seagen. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Seagen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Trastuzumab Emtansine NCT04457596 | Phase 3 | Anatomic Stage II Breast Cancer AJCC v8 |
| Trastuzumab emtansine NCT05673928 | Phase 2 | Metastatic Solid Tumor |
Latest
No recent events.
Follow Trastuzumab Emtansine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.